Bellerophon Therapeutics Price History
BLPHDelisted Stock | USD 0.71 0.01 1.43% |
If you're considering investing in Bellerophon Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Bellerophon Therapeutics stands at 0.71, as last reported on the 1st of February, with the highest price reaching 0.72 and the lowest price hitting 0.70 during the day. We have found twenty-three technical indicators for Bellerophon Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Bellerophon Therapeutics' Risk Adjusted Performance of (0.14), mean deviation of 5.45, and Standard Deviation of 12.01 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Bellerophon Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Bellerophon |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
BLPH |
Based on monthly moving average Bellerophon Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bellerophon Therapeutics by adding Bellerophon Therapeutics to a well-diversified portfolio.
Bellerophon Therapeutics Pink Sheet Price History Chart
There are several ways to analyze Bellerophon Stock price data. The simplest method is using a basic Bellerophon candlestick price chart, which shows Bellerophon Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Bellerophon Pink Sheet Price History Data
The price series of Bellerophon Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 9.9 with a coefficient of variation of 88.46. The prices are distributed with arithmetic mean of 4.41. The median price for the last 90 days is 0.94. The company had 1:15 stock split on 10th of February 2020. Bellerophon Therapeutics issued dividends on 2020-02-10.Open | High | Low | Close | Volume | ||
02/01/2025 | 0.70 | 0.72 | 0.70 | 0.71 | ||
07/24/2023 | 0.70 | 0.72 | 0.70 | 0.71 | 48,032 | |
07/21/2023 | 0.73 | 0.73 | 0.70 | 0.70 | 180,034 | |
07/20/2023 | 0.75 | 0.75 | 0.70 | 0.72 | 107,730 | |
07/19/2023 | 0.76 | 0.76 | 0.72 | 0.73 | 93,762 | |
07/18/2023 | 0.75 | 0.76 | 0.74 | 0.75 | 180,951 | |
07/17/2023 | 0.74 | 0.75 | 0.73 | 0.75 | 83,818 | |
07/14/2023 | 0.75 | 0.75 | 0.73 | 0.75 | 136,245 | |
07/13/2023 | 0.72 | 0.76 | 0.72 | 0.76 | 412,762 | |
07/12/2023 | 0.71 | 0.74 | 0.69 | 0.73 | 512,421 | |
07/11/2023 | 0.69 | 0.71 | 0.68 | 0.69 | 125,200 | |
07/10/2023 | 0.68 | 0.69 | 0.67 | 0.67 | 94,738 | |
07/07/2023 | 0.68 | 0.70 | 0.65 | 0.70 | 254,991 | |
07/06/2023 | 0.68 | 0.69 | 0.68 | 0.69 | 119,500 | |
07/05/2023 | 0.70 | 0.71 | 0.67 | 0.70 | 388,900 | |
07/03/2023 | 0.68 | 0.68 | 0.67 | 0.67 | 131,852 | |
06/30/2023 | 0.68 | 0.70 | 0.65 | 0.69 | 509,175 | |
06/29/2023 | 0.70 | 0.70 | 0.66 | 0.68 | 291,215 | |
06/28/2023 | 0.74 | 0.74 | 0.69 | 0.70 | 214,200 | |
06/27/2023 | 0.70 | 0.74 | 0.67 | 0.74 | 381,874 | |
06/26/2023 | 0.71 | 0.71 | 0.67 | 0.71 | 389,261 | |
06/23/2023 | 0.70 | 0.71 | 0.69 | 0.71 | 214,545 | |
06/22/2023 | 0.70 | 0.70 | 0.68 | 0.70 | 167,137 | |
06/21/2023 | 0.72 | 0.72 | 0.68 | 0.71 | 298,001 | |
06/20/2023 | 0.71 | 0.71 | 0.69 | 0.69 | 331,200 | |
06/16/2023 | 0.71 | 0.72 | 0.68 | 0.68 | 441,663 | |
06/15/2023 | 0.72 | 0.72 | 0.69 | 0.71 | 614,800 | |
06/14/2023 | 0.72 | 0.74 | 0.70 | 0.71 | 435,100 | |
06/13/2023 | 0.72 | 0.75 | 0.69 | 0.72 | 875,069 | |
06/12/2023 | 0.72 | 0.75 | 0.69 | 0.70 | 905,400 | |
06/09/2023 | 0.77 | 0.77 | 0.72 | 0.72 | 1,221,599 | |
06/08/2023 | 0.80 | 0.80 | 0.76 | 0.77 | 1,421,500 | |
06/07/2023 | 0.88 | 0.90 | 0.79 | 0.83 | 2,245,645 | |
06/06/2023 | 0.92 | 1.04 | 0.88 | 0.90 | 3,359,849 | |
06/05/2023 | 1.30 | 1.34 | 0.89 | 0.94 | 12,747,759 | |
06/02/2023 | 6.87 | 7.09 | 6.87 | 7.06 | 18,864 | |
06/01/2023 | 6.91 | 6.91 | 6.66 | 6.89 | 19,284 | |
05/31/2023 | 7.00 | 7.04 | 6.83 | 6.91 | 19,188 | |
05/30/2023 | 7.50 | 7.51 | 6.88 | 7.06 | 73,754 | |
05/26/2023 | 6.94 | 7.49 | 6.81 | 7.44 | 62,500 | |
05/25/2023 | 7.48 | 7.49 | 6.69 | 6.83 | 99,215 | |
05/24/2023 | 7.57 | 7.86 | 7.28 | 7.48 | 129,017 | |
05/23/2023 | 7.47 | 7.57 | 6.60 | 7.57 | 191,138 | |
05/22/2023 | 7.92 | 8.30 | 7.47 | 7.52 | 95,800 | |
05/19/2023 | 9.36 | 9.46 | 7.56 | 7.92 | 251,701 | |
05/18/2023 | 10.62 | 10.62 | 9.46 | 9.46 | 124,468 | |
05/17/2023 | 10.78 | 11.15 | 10.39 | 10.57 | 109,866 | |
05/16/2023 | 8.99 | 10.88 | 8.90 | 10.39 | 330,422 | |
05/15/2023 | 8.88 | 9.00 | 8.62 | 8.71 | 82,293 | |
05/12/2023 | 8.81 | 8.93 | 8.56 | 8.77 | 97,600 | |
05/11/2023 | 8.98 | 9.00 | 8.50 | 8.84 | 95,400 | |
05/10/2023 | 8.75 | 8.87 | 8.57 | 8.63 | 80,290 | |
05/09/2023 | 8.82 | 9.08 | 8.51 | 8.80 | 79,312 | |
05/08/2023 | 9.17 | 9.17 | 8.47 | 8.49 | 56,965 | |
05/05/2023 | 9.36 | 9.81 | 8.93 | 9.07 | 77,846 | |
05/04/2023 | 8.57 | 9.74 | 8.51 | 9.30 | 63,224 | |
05/03/2023 | 7.74 | 8.85 | 7.74 | 8.64 | 100,783 | |
05/02/2023 | 7.95 | 8.00 | 7.70 | 7.75 | 32,600 | |
05/01/2023 | 7.42 | 7.99 | 7.19 | 7.83 | 77,600 | |
04/28/2023 | 7.27 | 7.83 | 7.27 | 7.65 | 62,152 | |
04/27/2023 | 7.07 | 7.63 | 7.07 | 7.57 | 51,184 |
About Bellerophon Therapeutics Pink Sheet history
Bellerophon Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bellerophon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bellerophon Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bellerophon Therapeutics stock prices may prove useful in developing a viable investing in Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.
Bellerophon Therapeutics Pink Sheet Technical Analysis
Bellerophon Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
All Next | Launch Module |
Bellerophon Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bellerophon Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Bellerophon Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bellerophon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.14) | |||
Jensen Alpha | (2.28) | |||
Total Risk Alpha | (3.39) | |||
Treynor Ratio | (1.02) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |